Abstract

The present invention involves the discovery that synthetic thyroid hormones can be used as compositions to reduce intraocular pressure in vivo. Methods of screening synthetic thyroid hormones for effect on intraocular pressure, aqueous pressure, hydraulic conductivity, hyaluronic acid secretion, and extracellular matrix assembly are provided. Methods of treating glaucoma and treating excess intraocular pressure with synthetic thyroid hormones and compositions therefore are also provided.


Claims
Owners (US)

Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Apr 29, 2003
  • Application: Aug 10, 1999
    US US 37159299 A
  • Priority: Aug 10, 1999
    US US 37159299 A
  • Priority: Aug 20, 1997
    US US 91523297 A
  • Priority: Aug 20, 1996
    US US 2369796 P

Sign in to the Lens